Loading company financials…
NEW YORK STOCK EXCHANGE, INC. · Life Sciences Tools & Services · CIK 0000031791
$156.61
+0.38% · delayed ~15 min
Last price from Oct 21, 2026
$17.58B market value
From REVVITY, INC.'s FY2025 10-K, filed Feb 24, 2026 · read the filing
REVVITY makes measuring and control instruments. It took in $2.86B last year, which makes it a mid-sized company. Of every dollar it sells, about 8 cents is left as profit.
The financial picture is mixed, with profitability, growth and debt needing attention.
A conclusion from the filings, not a recommendation. Detailed figures and supporting evidence appear in their dedicated sections below.
Financial health
A mixed picture — some clear strengths and some weaknesses.
From REVVITY, INC.'s FY2025 annual filing · share price scored separately
Largest year-over-year changes in FY2025
Long-term debt
$3.15B → $2.63B
Cash
$1.16B → $919.9M
Shares in issue
120.6M → 112.3M
Capital spending
$86.6M → $73.5M
Measured against FY2024, from the 10-K filed Feb 24, 2026
Improved: -16.5%
$3.15B to $2.63BSignificant
Why it matters: Rising debt is not automatically bad — borrowing to build something that earns more than the interest is ordinary. It matters when it grows faster than the profit meant to service it.
Deteriorated: -20.9%
$1.16B to $919.9MSignificant
Why it matters: A falling cash pile is only a warning if the company is consuming it. Paying down debt, buying back stock and paying a dividend all reduce cash by choice.
How the latest move compares (quote delayed ~15 min), and what was published around it
RVTY rose 0.38% on the latest quote. The average Technology company tracked here moved −1.29%, and the S&P 500 −1.04%. That is 1.7 points above its sector and 1.4 points above the market.
Expectations
Not from the filings — what other people are betting on, and what the price already assumes.
The growth rate someone buying today is paying for, against what the company has delivered
At today's price, the market is paying for free cash flow to grow by about 14% a year for the next 10 years. Over the last 12 years it grew by about 13% a year.
The essentials
Each answered from the filings, with the numbers behind it.
Yes. It keeps about 8 cents of every dollar of sales as profit, earning $241.2M last year.
Slowly. Sales grew 3.7% last year.
Manageable, but notable. Clearing its debt would take about 3.9 years of cash flow. For every $1 it owes, it owns $2.47 in assets.
Core operating and valuation reference metrics
Whether the dividend is covered by what the business actually earns
It pays out 14 cents of every dollar of profit and keeps the rest, which leaves the payment comfortably covered. It paid out 6% of the cash its operations generated. It has paid in each of the last 12 years.
GoodFigures from the FY2025 annual filing
Last year it earned $241.2M and generated $582.9M of cash from operations.
Reported annual figures
As reported to the SEC, in USD. Hover or show sources to see where each figure came from.
| Income statement | FY202510-K · Feb 24, 2026Filing for FY2025 | FY202410-K · Feb 25, 2025Filing for FY2024 | FY202310-K · Feb 25, 2025Filing for FY2023 | FY202210-K · Mar 1, 2023Filing for FY2022 | FY202110-K · Mar 1, 2023Filing for FY2021 | ChangeFY2025 vs FY2024 |
|---|---|---|---|---|---|---|
| RevenueWhat is this? | $2.86B | $2.76B | $2.75B | $3.83B | $2.66B | +3.7% |
| Gross profit | — | — | $1.99B | $2.43B | $2.11B | — |
| Gross marginGross profit ÷ revenueWhat is this? | — | — | 72.3% | 63.6% | 79.2% | — |
| Selling, general and administrative | $991.9M | $994.1M | $1.02B | $975.2M | $716.5M | −0.2% |
| Operating income | $356.6M | $346.7M | $300.6M | $1.26B | $867.3M | +2.9% |
| Operating marginOperating income ÷ revenueWhat is this? | 12.5% | 12.6% | 10.9% | 32.9% | 32.6% | −0.1 pts |
| Interest expense | $92.2M | $96.3M | $98.8M | — | $49.7M | −4.3% |
| Income before tax | $268.3M | $316.1M | $183.0M | $1.20B | $800.1M | −15.1% |
| Net income | $241.2M | $270.4M | $693.1M | $943.2M | $727.9M | −10.8% |
| Net marginNet income ÷ revenueWhat is this? | 8.4% | 9.8% | 25.2% | 24.6% | 27.3% | −1.4 pts |
| Earnings per shareNet income ÷ shares outstanding at the period end — close to, but not the same as, the reported EPSWhat is this? | $2.15 | $2.24 | $5.62 | $7.47 | $6.49 | −4.1% |
† calculated from other reported figures, such as total liabilities as assets minus equity.
This company's latest filing beside its peers' stored scores
| Company | Health | F-Score | Revenue growth | Profit margin | P/E | Debt to equity |
|---|---|---|---|---|---|---|
| RVTYREVVITY, INC. · this page | 6.0/10 | 6/8 |
Insider activity, ownership stakes and what's coming — straight from EDGAR, before any article is written about it
Officers, directors and major shareholders must report within two business days of a trade.
Sold on the open market — 84 shares at $155.48 ($13.1K)
Holds 7,117 shares after this filing.
Sold on the open market
20 recent filings, newest first. Each is labelled from its form and item numbers, not from its wording.
Quarterly report for Q2 FY2026
Long-term debt -18.1% · Gross profit +6.2% · Gross margin +2.6 pts — against Q2 FY2025
Read the filingPublished results · Reported another event
Read the filingWrite down why you are following REVVITY, INC., what has to go right and what would change your mind, then see each new annual report measured against it. Sign in to start one.
Go deeper
Every figure above traces back to a filing in the timeline, each linked to the document itself.
Coverage from the last 30 days
Revvity Launches Signals LabGistics to Coordinate Scientific Workflows
Yahoo Finance ·
Revvity Launches Signals LabGistics Solution to Connect and Orchestrate Scientific Workflows
Yahoo Finance ·
1 Cash-Producing Stock to Own for Decades and 2 We Question
Yahoo Finance ·
Revvity (RVTY), What Is Drawing Fresh Attention Now?
Yahoo Finance ·
Every company's figures are checked for internal consistency: the balance sheet adding up, figures sharing one currency, cash flow and share counts within plausible ranges, and how recent the latest annual report is. Nothing here changes a figure.
Financial figures are from RVTY's 10-K for fiscal year 2025 (period ending 2025-12-28, filed Feb 24, 2026), reported under the US GAAP taxonomy. View the source filing.
3 of 4 scored areas had enough reported figures to judge
The score averages profitability, growth, debt and accounting. Accounting had too few reported figures and is left out of the average rather than counted as a weakness, so a company is never marked down for a figure it did not publish. Cash generation is shown for context and already feeds profitability. Valuation is scored separately, because a share price says nothing about whether the business is sound. 8 of the 9 Piotroski checks could be evaluated. How the score works
Each year scored only from its annual report as it was first filed
| Fiscal year | Health | F-Score | Scored from |
|---|---|---|---|
| FY2025 | 6.0 | 6/8 | 10-K, filed Feb 24, 2026 |
| FY2024 | 6.0 | 6/8 | 10-K, filed Feb 25, 2025 |
| FY2023 | 4.7 | 6/9 | 10-K, filed Feb 27, 2024 |
| FY2022 | 8.7 | 5/8 | 10-K, filed Mar 3, 2022 |
| FY2021 | 10.0 | 3/3 | 10-K, filed Mar 2, 2021 |
| FY2019 | 6.0 | 6/9 | 10-K, filed Feb 25, 2020 |
A later restatement never reaches back into an earlier year, and every year is scored without a share price, so the latest point can differ a little from the headline score, which uses today's price.
Every check behind the three models, and what each one tests
6 of 8 checks passed
Nine yes-or-no tests of whether this year's finances improved on last year's. One could not be evaluated and is excluded from the total rather than counted as a failure.
3.26
In the safe zone
For this model, above 2.99 is safe and below 1.81 is distress.
Distance from bankruptcy, from a model fitted on companies that did and did not go bust. It describes a balance sheet's shape today; it does not forecast a failure.
not reported — This company has not reported enough of the required figures to calculate this score.
This company has not reported enough of the required figures to calculate this score.
Screens eight accounting ratios for the pattern earnings manipulators tend to leave. A flag is a reason to read the filing closely, never evidence of wrongdoing.
Every figure above comes from the FY2025 filing as filed with the SEC.
Improved: -6.9%
120.6M to 112.3MSignificant
Why it matters: The company bought back stock, so each remaining holding owns slightly more of it. Worth checking it was not funded by borrowing.
Changed: -15.1%
$86.6M to $73.5MSignificant
Why it matters: Neither good nor bad on its own. Heavy spending is a company building capacity or a company struggling to stand still, and the two look identical in this figure.
Deteriorated: -10.8%
$270.4M to $241.2MNotable
Why it matters: Profit swings far more than sales do, and one-off items — a legal settlement, a tax charge, an asset sale — move it without the underlying business changing.
Deteriorated: −1.4 pts
9.8% to 8.4%Notable
Why it matters: What survives to the very end of each sale. Worth reading beside revenue: growing sales on a shrinking margin means the company is buying its growth.
Deteriorated: -6.0%
$541.7M to $509.4MNotable
Why it matters: Cash left after paying for the plant that produced it — the money genuinely available for dividends, buybacks or paying down debt. Harder to flatter than profit.
Q2 FY2026 against Q2 FY2025, from the 10-Q filed Aug 11, 2026 — read it.
Improved: -18.1%
$3.21B to $2.63BSignificant
Why it matters: Rising debt is not automatically bad — borrowing to build something that earns more than the interest is ordinary. It matters when it grows faster than the profit meant to service it.
Improved: +6.2%
$392.6M to $416.9MNotable
Why it matters: What is left of sales after the direct cost of producing them. It normally moves with revenue, so a move out of step with revenue is the part worth noticing.
Improved: +2.6 pts
54.5% to 57.1%Notable
Why it matters: What survives each sale before overheads. Falling gross margin usually means the company is discounting or its input costs rose — it is the earliest place pricing pressure shows.
Improved: -4.1%
116.3M to 111.6MNotable
Why it matters: The company bought back stock, so each remaining holding owns slightly more of it. Worth checking it was not funded by borrowing.
Q2 FY2026 against Q1 FY2026, from the 10-Q filed Aug 11, 2026 — read it. Quarter-to-quarter moves include seasonal swings — a retailer's holiday quarter — which the year-earlier comparison removes.
Improved: +17.7%
$75.9M to $89.3MSignificant
Why it matters: Profit from running the business, before interest and tax. Less exposed than profit to one-off financing and tax items, so a clearer read on the business itself.
Improved: +27.3%
$40.7M to $51.8MSignificant
Why it matters: Profit swings far more than sales do, and one-off items — a legal settlement, a tax charge, an asset sale — move it without the underlying business changing.
Improved: +27.3%
$0.36 to $0.46Significant
Why it matters: Profit divided by the shares in issue at the period end, so it sits close to but not on the company's own reported figure. It can rise with no growth in profit when the company buys back stock — read it beside the share count.
Improved: +18.9%
$860.3M to $1.02BSignificant
Why it matters: A falling cash pile is only a warning if the company is consuming it. Paying down debt, buying back stock and paying a dividend all reduce cash by choice.
Improved: +7.5%
$387.7M to $416.9MNotable
Why it matters: What is left of sales after the direct cost of producing them. It normally moves with revenue, so a move out of step with revenue is the part worth noticing.
Improved: +2.6 pts
54.5% to 57.1%Notable
Why it matters: What survives each sale before overheads. Falling gross margin usually means the company is discounting or its input costs rose — it is the earliest place pricing pressure shows.
Improved: +1.6 pts
10.7% to 12.2%Notable
Why it matters: What survives each sale after running the business. A falling operating margin beside a steady gross margin points at overheads — wages, marketing, research — rather than pricing.
Improved: +1.4 pts
5.7% to 7.1%Notable
Why it matters: What survives to the very end of each sale. Worth reading beside revenue: growing sales on a shrinking margin means the company is buying its growth.
5 other measures barely moved. Figures compare the two most recent annual filings — read the latest one. Moves are graded on fixed lines — 5%, 15% and 40% for amounts, and 1, 3 and 8 points for margins — as notable, significant or critical. Nothing here reads the management commentary, which is where a company explains its own numbers.
These coincide with the move in time. None is presented as its cause: a price can move on news that names no company, on the wider market, or on trading that no document records.
Filter by minute, hour, day or week — or compare against peers
Loading price history…
Discounted at 8%–10% a year, with growth settling to 2.5% after 10 years. Those rates are ordinary choices, not measurements: across that range the assumed growth works out between 12% and 17%. This describes what the price implies — it is not a forecast, and not a view on whether the price is right.
Opinions from 24 analysts covering this company, as of . Their views, not this site's.
Of 24 analysts publishing on this company, 4 say strong buy, 6 say buy and 14 say hold. Analysts are paid to publish a view and are wrong often; the split above says how much they agree with each other, which is the part a single headline rating hides.
Published by Finnhub. Analyst coverage skews towards larger companies and towards optimism — sell ratings are rare across the whole market, so a company with none is ordinary rather than endorsed.
Measured on and published about a week later — this is a fortnightly snapshot, not a live position.
About 5.6% of this company's shares have been borrowed and sold by people expecting to buy them back cheaper. That is a bet the price falls. Those people can be wrong, and when a heavily shorted share rises they have to buy it back, which pushes it up further.
Collected by FINRA from broker-dealers twice a month. It counts positions, not intentions, and some of it is hedging rather than a directional bet against the company.
Nothing in this section is a figure this company reported about itself. These are expectations and positions — what the price implies, what analysts have published, what short sellers are betting, and what large funds held at the last count. WylthIQ reports them; it does not endorse them, does not forecast prices, and takes no view on whether any of them will turn out to be right.
The trailing P/E is 91.0x — a high multiple relative to the current trailing profit.
This company has not reported enough of the required figures to calculate this score.
| 3.7% |
| 8.4% |
| 72.90x |
| 0.68x |
| WATWATERS CORP /DE/ | 9.0/10 | 6/9 | 7.0% | 20.3% | 42.22x | 0.98x |
|---|
| MTDMETTLER TOLEDO INTERNATIONAL INC/ | 8.7/10 | 7/9 | 4.0% | 21.6% | 39.46x | -158.08x |
|---|
| CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC. | 2.0/10 | 4/8 | -0.9% | -3.6% | — | 1.24x |
|---|
| Median of peers | 8.7/10 | — | 4.0% | 20.3% | 40.84x | 0.98x |
|---|
Peers come from the company's industry classification. A difference describes the companies; it does not rank them.
Holds 14,781 shares after this filing.
Sold on the open market — 7,330 shares at $140.88 ($1.0M)
Holds 6,635 shares after this filing.
Gifted shares — 285 shares
Holds 6,985 shares after this filing.
Gifted shares — 27,785 shares
Holds 13,729 shares after this filing.
Gifted shares — 27,785 shares
Holds 91,494 shares after this filing.
Gifted shares — 7,636 shares
Holds 105,676 shares after this filing.
Gifted shares — 7,636 shares
Holds 54,219 shares after this filing.
Gifted shares — 59,650 shares
Holds 46,026 shares after this filing.
Gifted shares — 59,650 shares
Holds 59,650 shares after this filing.
Sold on the open market — 85 shares at $109.48 ($9.3K)
Holds 7,201 shares after this filing.
Notice filed ahead of a planned sale — the sale itself has not necessarily happened yet.
Filed notice to sell 84 shares ($13.1K) on or after .
Shares originally obtained via Restricted Stock Vesting.
Filed notice to sell 1,631 shares ($235.7K) on or after .
Shares originally obtained via Restricted Stock Vesting.
Filed notice to sell 7,330 shares ($1.0M) on or after .
Shares originally obtained via Restricted Stock Vesting.
Filed notice to sell 85 shares ($9.3K) on or after .
Shares originally obtained via Restricted Stock Vesting.
Not investment advice, and not a signal to act on by itself — a filing says what happened, not why, and insiders trade for ordinary reasons having nothing to do with where they think the company is headed.
Quarterly report for Q1 FY2026
Revenue +7.0% · Long-term debt -16.9% · Cash -24.4% — against Q1 FY2025
Published results · Reported another event
Read the filingAmended its charter or changed its financial year · Held a shareholder vote
Read the filingProxy statement for a shareholder meeting
Read the filingAnnual report for FY2025
Profit margin −1.4 pts · Long-term debt -16.5% · Cash -20.9% — against FY2024
Read the filingPublished results
Read the filingPublished results · Made a Regulation FD disclosure
Read the filingQuarterly report for Q3 FY2025
Operating margin −2.6 pts · Profit -50.6% · Earnings per share -47.1% — against Q3 FY2024
Read the filingPublished results
Read the filingHad a director or senior officer leave or join
Read the filingQuarterly report for Q2 FY2025
Cash -20.5% · Shares in issue -5.7% · Operating income +5.9% — against Q2 FY2024
Read the filingPublished results
Read the filingQuarterly report for Q1 FY2025
Operating margin +4.1 pts · Operating income +63.7% · Profit +62.4% — against Q1 FY2024
Read the filingPublished results
Read the filingAmended its charter or changed its financial year · Held a shareholder vote
Read the filingProxy statement for a shareholder meeting
Read the filingAnnual report for FY2024
Operating margin +1.7 pts · Profit -61.0% · Profit margin −15.4 pts — against FY2023
Read the filingPublished results
Read the filingRevvity (RVTY) Stock Could Be 12% Stretched On Cash Flow
Yahoo Finance ·
Primary sources and further research